ZA823760B - Apap antacid composition - Google Patents

Apap antacid composition

Info

Publication number
ZA823760B
ZA823760B ZA823760A ZA823760A ZA823760B ZA 823760 B ZA823760 B ZA 823760B ZA 823760 A ZA823760 A ZA 823760A ZA 823760 A ZA823760 A ZA 823760A ZA 823760 B ZA823760 B ZA 823760B
Authority
ZA
South Africa
Prior art keywords
apap
antacid composition
antacid
composition
apap antacid
Prior art date
Application number
ZA823760A
Other languages
English (en)
Inventor
Francis J Sterbenz
Leonard Weintraub
George L Cohen
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ZA823760B publication Critical patent/ZA823760B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA823760A 1981-07-13 1982-05-28 Apap antacid composition ZA823760B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28256581A 1981-07-13 1981-07-13

Publications (1)

Publication Number Publication Date
ZA823760B true ZA823760B (en) 1983-03-30

Family

ID=23082085

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA823760A ZA823760B (en) 1981-07-13 1982-05-28 Apap antacid composition

Country Status (17)

Country Link
JP (1) JPS5823617A (xx)
KR (1) KR840000234A (xx)
AR (1) AR228661A1 (xx)
AU (1) AU8436082A (xx)
BE (1) BE893827A (xx)
CA (1) CA1182049A (xx)
DE (1) DE3226178A1 (xx)
DK (1) DK309282A (xx)
FR (1) FR2509174A1 (xx)
GB (1) GB2103087A (xx)
GR (1) GR76197B (xx)
IT (1) IT1148199B (xx)
NL (1) NL8202773A (xx)
NO (1) NO822385L (xx)
PT (1) PT75234B (xx)
SE (1) SE8204288L (xx)
ZA (1) ZA823760B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
AU5882298A (en) * 1997-01-29 1998-08-18 Chong Kun Dang Corporation New analgesic composition
GB9704524D0 (en) 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
WO2006049978A1 (en) * 2004-10-28 2006-05-11 Novartis Ag Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent fr enhanced absorption
AU2006317530B2 (en) 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
GB0607085D0 (en) 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
GB0813929D0 (en) * 2008-07-30 2008-09-03 Glaxo Group Ltd Novel method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241201A (en) * 1968-07-23 1971-08-04 Sterling Winthrop Group Ltd Improvements in or relating to effervescent pharmaceutical compositions
GB1221038A (en) * 1969-09-18 1971-02-03 H & T Kirby & Company Ltd Improvements in effervescent tablet compositions
GB1359614A (en) * 1971-04-06 1974-07-10 Dev Et De Rech Soc Fr De Method for the manufacture of effervescent tablets

Also Published As

Publication number Publication date
NL8202773A (nl) 1983-02-01
NO822385L (no) 1983-01-14
CA1182049A (en) 1985-02-05
DK309282A (da) 1983-01-14
SE8204288L (sv) 1983-01-14
AR228661A1 (es) 1983-03-30
FR2509174A1 (fr) 1983-01-14
BE893827A (fr) 1983-01-12
IT8248788A0 (it) 1982-07-09
PT75234B (en) 1985-10-04
JPS5823617A (ja) 1983-02-12
DE3226178A1 (de) 1983-01-20
GB2103087A (en) 1983-02-16
IT1148199B (it) 1986-11-26
AU8436082A (en) 1983-01-20
PT75234A (en) 1982-08-01
GR76197B (xx) 1984-08-03
KR840000234A (ko) 1984-02-18
SE8204288D0 (sv) 1982-07-12

Similar Documents

Publication Publication Date Title
GB2112284B (en) Oral composition
GB2109098B (en) Vaporiser
GB2108952B (en) Improved cement composition
ZA854876B (en) Antacid composition
JPS57179117A (en) Analgesic composition and use
JPS57183724A (en) Medicinal composition and manufacture
JPS57149230A (en) Medicinal composition
ZA823760B (en) Apap antacid composition
PH19779A (en) Oral composition
JPS57205368A (en) Ceramic composition
ZA825793B (en) Dispersing composition
ZA829195B (en) Fuel composition
JPS57206615A (en) Medicinal composition containing guanfasin
JPS57175362A (en) Pasturizing composition
JPS57156357A (en) Sulfur-aggregate composition and manufacture
JPS57176947A (en) Composition and compound
JPS57179242A (en) Polyimide composition
JPS57125758A (en) Respirator
JPS57188456A (en) Ceramic composition
JPS57175771A (en) Cement composition
JPS57166351A (en) Cement composition
JPS57139070A (en) Medicinal composition
JPS57169418A (en) Guanopyrimidine-containing novel medicinal composition
ZA827279B (en) Oral composition
JPS57168642A (en) Breathing excerciser